Salarius Pharmaceuticals, Inc. — Director's Dealing 2017

Nov 6, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2017-10-30

Reporting Person: Tung Roger D (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5837	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.6	2024-04-09	Common Stock (4670.0)		Direct
Stock Option (right to buy)	$5.44	2024-11-14	Common Stock (4670.0)		Direct

Footnotes

F1: 25% of the total shares underlying this option vested on April 9, 2015 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date.

F2: 25% of the total shares underlying this option vested on November 14, 2015 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date.